4.5 Review

CLN3, the protein associated with batten disease: Structure, function and localization

Journal

JOURNAL OF NEUROSCIENCE RESEARCH
Volume 79, Issue 5, Pages 573-583

Publisher

WILEY
DOI: 10.1002/jnr.20367

Keywords

Batten disease; CLN3; neurodegeneration; lysosomal function

Categories

Funding

  1. NIMH NIH HHS [T32 MH065181, NIH T32 MH065181] Funding Source: Medline
  2. NINDS NIH HHS [R01 NS044310, NS36610, NS44310, NS40580, R01 NS036610] Funding Source: Medline

Ask authors/readers for more resources

Batten disease, an inherited neurodegenerative storage disease affecting children, results from the autosomal recessive inheritance of mutations in Cln3. The function of the CLN3 protein remains unknown. A key to understanding the pathology of this devastating disease will be to elucidate the function of CLN3 at the cellular level. CLN3 has proven difficult to study as it is predicted to be a membrane protein expressed at relatively low levels. This article is a critical review of various approaches used in examining the structure, trafficking, and localization of CLN3. We conclude that CLN3 is likely resident in the lysosomal/endosomal membrane. Different groups have postulated conflicting orientations for CLN3 within this membrane. In addition, CLN3 undergoes several post-translational modifications and is trafficked through the encloplasmic reticulum and Golgi. Recent evidence also suggests that CLN3 traffics via the plasma membrane. Although the function of this protein remains elusive, it is apparent that genetic alterations in C1n3 may have a direct affect on lysosomal function. (C) 2005 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available